Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
ARO Q&A #3: Supplemental fees
-
wrote on 29 Jun 2022, 18:15 last edited by Jennifer Carroll 7 Apr 2022, 17:00
Q: What types of files do not incur a supplemental page fee?
A: Minor updates, renewals and modular submissions (note: modular libraries and series DO incur this supplemental page fee)